WASHINGTON (dpa-AFX) - Proteostasis Therapeutics, Inc. (PTI) Thursday announced the pricing of its initial public offering of 6.25 million common shares at a public offering price of $8.00 per share. The company has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock from the company at the public offering price.
The shares will be trading on the NASDAQ Global Market on February 11, 2016 under the ticker symbol 'PTI.' The offering is expected to close on February 17, 2016.
Leerink Partners and RBC Capital Markets are acting as joint book-running managers. Baird and H.C. Wainwright & Co. are acting as co-managers.
Copyright RTT News/dpa-AFX